1. Comment on Okabayashi et al. Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients. Diabetes Care 2014;37:1516–1524
- Author
-
Marina Verçoza Viana and Luciana Verçoza Viana
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Glucose control ,Endocrinology, Diabetes and Metabolism ,Population ,Surgical intensive care unit ,Hypoglycemia ,Postoperative Complications ,Diabetes mellitus ,Surgical site ,Internal Medicine ,medicine ,Humans ,Hypoglycemic Agents ,Insulin ,Surgical Wound Infection ,Intensive care medicine ,education ,Glycemic ,Advanced and Specialized Nursing ,education.field_of_study ,business.industry ,Critically ill ,medicine.disease ,Intensive Care Units ,Anesthesia ,Female ,business - Abstract
Hyperglycemia is a major concern in critically ill patients, especially in surgical patients. The optimal target of glucose control in this population and the best method to achieve this goal in order to avoid hypoglycemia is unknown. Okabayashi et al. (1) demonstrated that intensive glucose control (glucose target 80–110 mg/dL) compared with intermediate glucose control (glucose target 140–180 mg/dL) in a selected group of patients who underwent hepato-biliary-pancreatic surgery was feasible using a closed-loop glycemic sensor, without hypoglycemic events and, more important, with a decreased number of surgical site infections and shorter hospitalization length. The result of this trial reinforces the need for new trials using …
- Published
- 2014